Old World cutaneous leishmaniasis in American soldiers underscores diagnostic and therapeutic options

References

• Herwaldt BL. Leishmaniasis. Lancet354(9185), 1191–1199 (1999).
   PubMed Web of Science ®Google Scholar
• Hepburn NC. Cutaneous leishmaniasis: an overview. J. Postgrad. Med.49(1), 50–54 (2003).
   PubMedGoogle Scholar
• Norton SA, Frankenburg S, Klaus SN. Cutaneous leishmaniasis acquired during military service in the Middle East. Arch. Dermatol.128(1), 83–87 (1992).
   PubMedGoogle Scholar
• Walsh DS, Balagon MV, Abalos RM et al. Multiple lesions of sporotrichoid leishmaniasis in a Filipino expatriate. J. Am. Acad. Dermatol.36(5 Pt 2), 847–849 (1997).
   PubMedGoogle Scholar
• Kubba R, al-Gindan Y, el-Hassan AM, Omer AH, Kutty MK, Saeed MB. Dissemination in cutaneous leishmaniasis. II. Satellite papules and subcutaneous induration. Int. J. Dermatol.27(10), 702–706 (1988).
   PubMed Web of Science ®Google Scholar
• Jappe U. Unusual skin infections in military personnel. Clin. Dermatol.20(4), 425–434 (2002).
   PubMedGoogle Scholar
• Magill AJ, Grogl M, Gasser RA Jr, Sun W, Oster CN. Visceral infection caused by Leishmania tropica in veterans of Operation Desert Storm. N. Engl. J. Med.328(19), 1383–1387 (1993).
   PubMed Web of Science ®Google Scholar
• Salmanpour R, Handjani F, Zerehsaz F, Ardehali S, Panjehshahin MR. Erysipeloid leishmaniasis: an unusual clinical presentation. Eur. J. Dermatol.9(6), 458–459 (1999).
   PubMedGoogle Scholar
• Crum NF, Aronson NE, Lederman ER, Rusnak JM, Cross JH. History of U.S. military contributions to the study of parasitic diseases. Mil. Med.170(4 Suppl.), 17–29 (2005).
   PubMedGoogle Scholar
• Update: Cutaneous leishmaniasis in U.S. military personnel – Southwest/Central Asia, 2002–2004. Morb. Mortal. Weekly Rep.53(12), 264–265 (2004).
   PubMedGoogle Scholar
• Weina PJ, Neafie RC, Wortmann G, Polhemus M, Aronson NE. Old world leishmaniasis: an emerging infection among deployed US military and civilian workers. Clin. Infect. Dis.39(11), 1674–1680 (2004).
   PubMed Web of Science ®Google Scholar
• Yanik M, Gurel MS, Simsek Z, Kati M. The psychological impact of cutaneous leishmaniasis. Clin. Exp. Dermatol.29(5), 464–467 (2004).
   PubMed Web of Science ®Google Scholar
• Willard RJ, Jeffcoat AM, Benson PM, Walsh DS. Cutaneous leishmaniasis in soldiers from Fort Campbell, Kentucky returning from Operation Iraqi Freedom highlights diagnostic and therapeutic options. J. Am. Acad. Dermatol.52(6), 977–987 (2005).
   PubMed Web of Science ®Google Scholar
• Alrajhi AA, Ibrahim EA, De Vol EB, Khairat M, Faris RM, Maguire JH. Fluconazole for the treatment of cutaneous leishmaniasis caused by Leishmania major. N. Engl. J. Med.346(12), 891–895 (2002).
   PubMed Web of Science ®Google Scholar
• Soto JM, Toledo JT, Gutierrez P et al. Treatment of cutaneous leishmaniasis with a topical antileishmanial drug (WR279396): phase 2 pilot study. Am. J. Trop. Med. Hyg.66(2), 147–151 (2002).
   PubMed Web of Science ®Google Scholar
• Faber WR, Oskam L, van Gool T et al. Value of diagnostic techniques for cutaneous leishmaniasis. J. Am. Acad. Dermatol.49(1), 70–74 (2003).
   PubMed Web of Science ®Google Scholar
• Marques MJ, Volpini AC, Machado-Coelho GL et al. Comparison of polymerase chain reaction with other laboratory methods for the diagnosis of American cutaneous leishmaniasis: diagnosis of cutaneous leishmaniasis by polymerase chain reaction. Diag. Microbiol. Infect. Dis.54(1), 37–43 (2006).
   PubMedGoogle Scholar
• Wortmann G, Hochberg L, Houng HH et al. Rapid identification of leishmania complexes by a real-time PCR assay. Am. J. Trop. Med. Hyg.73(6), 999–1004 (2005).
   PubMed Web of Science ®Google Scholar
• Wortmann G, Sweeney C, Houng HS et al. Rapid diagnosis of leishmaniasis by fluorogenic polymerase chain reaction. Am. J. Trop. Med. Hyg.65(5), 583–587 (2001).
   PubMedGoogle Scholar
• Navin TR, Arana BA, Arana FE, de Merida AM, Castillo AL, Pozuelos JL. Placebo-controlled clinical trial of meglumine antimonate (glucantime) vs. localized controlled heat in the treatment of cutaneous leishmaniasis in Guatemala. Am. J. Trop. Med. Hyg.42(1), 43–50 (1990).
   PubMed Web of Science ®Google Scholar
• Velasco-Castrejon O, Walton BC, Rivas-Sanchez B et al. Treatment of cutaneous leishmaniasis with localized current field (radio frequency) in Tabasco, Mexico. Am. J. Trop. Med. Hyg.57(3), 309–312 (1997).
   PubMed Web of Science ®Google Scholar
• Neva FA, Petersen EA, Corsey R, Bogaert H, Martinez D. Observations on local heat treatment for cutaneous leishmaniasis. Am. J. Trop. Med. Hyg.33(5), 800–804 (1984).
   PubMed Web of Science ®Google Scholar
• Sacks DL, Barral A, Neva FA. Thermosensitivity patterns of Old vs. New World cutaneous strains of Leishmania growing within mouse peritoneal macrophages in vitro. Am. J. Trop. Med. Hyg.32(2), 300–304 (1983).
   PubMed Web of Science ®Google Scholar
• Lobo IM, Soares MB, Correia TM et al. Heat therapy for cutaneous leishmaniasis elicits a systemic cytokine response similar to that of antimonial (Glucantime) therapy. Trans. R. Soc. Trop. Med. Hyg.DOI: 10.1016/j.trstmh.2005.08.011 (2005).
   Google Scholar
• Bassiouny A, El Meshad M, Talaat M, Kutty K, Metawaa B. Cryosurgery in cutaneous leishmaniasis. Br. J. Dermatol.107(4), 467–474 (1982).
   PubMed Web of Science ®Google Scholar
• Panagiotopoulos A, Stavropoulos PG, Hasapi V, Papakonstantinou AM, Petridis A, Katsambas A. Treatment of cutaneous leishmaniasis with cryosurgery. Int. J. Dermatol.44(9), 749–752 (2005).
   PubMed Web of Science ®Google Scholar
• Hepburn NC. Cutaneous leishmaniasis: current and future management. Expert Rev. Anti-infect. Ther.1(4), 563–570 (2003).
   PubMedGoogle Scholar
• Garnier T, Croft SL. Topical treatment for cutaneous leishmaniasis. Curr. Opin. Investig. Drugs.3(4), 538–544 (2002).
   PubMedGoogle Scholar
• el-SafiSH, Murphy AG, Bryceson AD, Neal RA. A double-blind clinical trial of the treatment of cutaneous leishmaniasis with paromomycin ointment. Trans. R. Soc. Trop. Med. Hyg.84(5), 690–691 (1990).
   PubMed Web of Science ®Google Scholar
• El-On J, Halevy S, Grunwald MH, Weinrauch L. Topical treatment of Old World cutaneous leishmaniasis caused by Leishmania major: a double-blind control study. J. Am. Acad. Dermatol.27(2 Pt 1), 227–231 (1992).
   PubMed Web of Science ®Google Scholar
• El-On J, Livshin R, Even-Paz Z, Hamburger D, Weinrauch L. Topical treatment of cutaneous leishmaniasis. J. Invest. Dermatol.87(2), 284–288 (1986).
   PubMed Web of Science ®Google Scholar
• Asilian A, Jalayer T, Whitworth JA, Ghasemi RL, Nilforooshzadeh M, Olliaro P. A randomized, placebo-controlled trial of a two-week regimen of aminosidine (paromomycin) ointment for treatment of cutaneous leishmaniasis in Iran. Am. J. Trop. Med. Hyg.53(6), 648–651 (1995).
   PubMed Web of Science ®Google Scholar
• Ben Salah A, Zakraoui H, Zaatour A et al. A randomized, placebo-controlled trial in Tunisia treating cutaneous leishmaniasis with paromomycin ointment. Am. J. Trop. Med. Hyg.53(2), 162–166 (1995).
   PubMed Web of Science ®Google Scholar
• Iraji F, Sadeghinia A. Efficacy of paromomycin ointment in the treatment of cutaneous leishmaniasis: results of a double-blind, randomized trial in Isfahan, Iran.Ann. Trop. Med. Parasitol.99(1), 3–9 (2005).
   PubMed Web of Science ®Google Scholar
• Asilian A, Jalayer T, Nilforooshzadeh M et al. Treatment of cutaneous leishmaniasis with aminosidine (paromomycin) ointment: double-blind, randomized trial in the Islamic Republic of Iran. Bull. World Health Organ.81(5), 353–359 (2003).
   PubMed Web of Science ®Google Scholar
• Grogl M, Schuster BG, Ellis WY, Berman JD. Successful topical treatment of murine cutaneous leishmaniasis with a combination of paromomycin (Aminosidine) and gentamycin. J. Parasitol.85(2), 354–359 (1999).
   PubMed Web of Science ®Google Scholar
• Miranda-Verastegui C, Llanos-Cuentas A, Arevalo I, Ward BJ, Matlashewski G. Randomized, double-blind clinical trial of topical imiquimod 5% with parenteral meglumine antimoniate in the treatment of cutaneous leishmaniasis in Peru. Clin. Infect. Dis.40(10), 1395–1403 (2005).
   PubMed Web of Science ®Google Scholar
• Aronson NE, Wortmann GW, Johnson SC et al. Safety and efficacy of intravenous sodium stibogluconate in the treatment of leishmaniasis: recent U.S. military experience. Clin. Infect. Dis.27(6), 1457–1464 (1998).
   PubMed Web of Science ®Google Scholar
• Wortmann G, Miller RS, Oster C, Jackson J, Aronson N. A randomized, double-blind study of the efficacy of a 10- or 20-day course of sodium stibogluconate for treatment of cutaneous leishmaniasis in United States military personnel. Clin. Infect. Dis.35(3), 261–267 (2002).
   PubMed Web of Science ®Google Scholar
• Wortmann GW, Aronson NE, Byrd JC, Grever MR, Oster CN. Herpes zoster and lymphopenia associated with sodium stibogluconate therapy for cutaneous leishmaniasis. Clin. Infect. Dis.27(3), 509–512 (1998).
   PubMed Web of Science ®Google Scholar
• Consigli J, Danielo C, Gallerano V, Papa M, Guidi A. Cutaneous leishmaniasis: successful treatment with itraconazole. Int. J. Dermatol.DOI: 10.1111/j.1365–4632.2004.02429.x (2004).
   Google Scholar
• Morelli P, Gianelli E, Calattini S, Corbellino M, Antinori S, Meroni L. Itraconazole can be effective in the treatment of sporotrichoid leishmaniasis. J. Travel Med.11(5), 328–330 (2004).
   PubMed Web of Science ®Google Scholar
• Nassiri-Kashani M, Firooz A, Khamesipour A et al. A randomized, double-blind, placebo-controlled clinical trial of itraconazole in the treatment of cutaneous leishmaniasis. J. Eur. Acad. Dermatol. Venereol.19(1), 80–83 (2005).
   PubMed Web of Science ®Google Scholar
• El Hajj L, Thellier M, Carriere J, Bricaire F, Danis M, Caumes E. Localized cutaneous leishmaniasis imported into Paris: a review of 39 cases. Int. J. Dermatol.43(2), 120–125 (2004).
   PubMed Web of Science ®Google Scholar
• Ozgoztasi O, Baydar I. A randomized clinical trial of topical paromomycin versus oral ketoconazole for treating cutaneous leishmaniasis in Turkey. Int. J. Dermatol.36(1), 61–63 (1997).
   PubMed Web of Science ®Google Scholar